The Australian Technical Advisory Group on Immunisation (ATAGI) has developed advice on the introduction of meningococcal ACWY vaccine (Nimenrix®) for adolescents through the National Immunisation Program (NIP).
It includes information about:
- recommendations for the use of meningococcal ACWY vaccine
- safety and effectiveness of the meningococcal ACWY vaccine
- eligibility for NIP funded meningococcal ACWY vaccine
- contraindications for the meningococcal ACWY vaccine
- meningococcal vaccines available for use in Australia.
ATAGI statement on meningococcal ACWY vaccine (Nimenrix®) for adolescents
About this resource
Publication date:
Publication type:
Standard
Language:
English